{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:59:40Z","timestamp":1755694780443},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:00:00Z","timestamp":1588377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Auton Res"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10286-020-00684-3","type":"journal-article","created":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T17:02:41Z","timestamp":1588438961000},"page":"191-192","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dysautonomia in early Parkinson disease: a window into the determinants of functional disability and an opportunity for early intervention"],"prefix":"10.1007","volume":"30","author":[{"given":"Aristide","family":"Merola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Coon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,2]]},"reference":[{"key":"684_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-020-00672-7","author":"M Sklerov","year":"2020","unstructured":"Sklerov M, Shih CH, Browner N, Palma JA, Styner M, Dayan E (2020) Longitudinal change in autonomic symptoms predicts activities of daily living and depression in Parkinson's disease. Clin Auton Res. https:\/\/doi.org\/10.1007\/s10286-020-00672-7[published online ahead of print, 2020 Feb 20]","journal-title":"Clin Auton Res"},{"key":"684_CR2","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"Parkinson Progression Marker Initiative","year":"2011","unstructured":"Parkinson Progression Marker Initiative (2011) The Parkinson progression marker initiative (PPMI). Prog Neurobiol 95:629\u2013635. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005","journal-title":"Prog Neurobiol"},{"key":"684_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/mds.27268","volume":"33","author":"A Merola","year":"2018","unstructured":"Merola A, Romagnolo A, Rosso M et al (2018) Autonomic dysfunction in Parkinson's disease: a prospective cohort study. Mov Disord 33:391\u2013397. https:\/\/doi.org\/10.1002\/mds.27268","journal-title":"Mov Disord"},{"key":"684_CR4","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ (2004) Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 19:1306\u20131312. https:\/\/doi.org\/10.1002\/mds.20153","journal-title":"Mov Disord"},{"key":"684_CR5","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","volume":"87","author":"DM Sletten","year":"2012","unstructured":"Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W (2012) COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc 87:1196\u20131201. https:\/\/doi.org\/10.1016\/j.mayocp.2012.10.013","journal-title":"Mayo Clin Proc"},{"key":"684_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.parkreldis.2017.11.344","volume":"47","author":"A Merola","year":"2018","unstructured":"Merola A, Sawyer RP, Artusi CA et al (2018) Orthostatic hypotension in Parkinson disease: Impact on health care utilization. Parkinsonism Relat Disord 47:45\u201349. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.11.344","journal-title":"Parkinsonism Relat Disord"},{"key":"684_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","volume":"78","author":"CA Haaxma","year":"2007","unstructured":"Haaxma CA, Bloem BR, Borm GF et al (2007) Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry 78:819\u2013824. https:\/\/doi.org\/10.1136\/jnnp.2006.103788","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"684_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.parkreldis.2016.12.026","volume":"36","author":"AJ Perrin","year":"2017","unstructured":"Perrin AJ, Nosova E, Co K et al (2017) Gender differences in Parkinson's disease depression. Parkinsonism Relat Disord 36:93\u201397. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.12.026","journal-title":"Parkinsonism Relat Disord"},{"key":"684_CR9","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/jnnp-2019-320846","volume":"90","author":"A Pilotto","year":"2019","unstructured":"Pilotto A, Romagnolo A, Tuazon JA et al (2019) Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in \u03b1-synucleinopathies. J Neurol Neurosurg Psychiatry 90:1257\u20131263. https:\/\/doi.org\/10.1136\/jnnp-2019-320846","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"684_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.27186","volume":"33","author":"EA Coon","year":"2018","unstructured":"Coon EA, Cutsforth-Gregory JK, Benarroch EE (2018) Neuropathology of autonomic dysfunction in synucleinopathies. Mov Disord 33:349\u2013358. https:\/\/doi.org\/10.1002\/mds.27186","journal-title":"Mov Disord"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-020-00684-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-020-00684-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-020-00684-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T17:10:47Z","timestamp":1620061847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-020-00684-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,2]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["684"],"URL":"https:\/\/doi.org\/10.1007\/s10286-020-00684-3","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"value":"0959-9851","type":"print"},{"value":"1619-1560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,2]]},"assertion":[{"value":"17 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"AM has received grant support from Lundbeck, advisory board compensation from Lundbeck, and speaker honoraria from Theravance Biopharma. EC has nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}